World
TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA
TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...
March 11, 2024 | News
Merck Opens new € 20 Million Distribution Center in Brazil
New site in Cajamar, São Paulo has 2.5 times more storage capacity than previous space in Cotia, São Paulo 13,000 square-meters space for ...
March 04, 2024 | News
Waters Launches HPLC/UPLC-MALS Integration Software for Advanced Biologic Drug Characterization
At Pittcon 2024, Waters Corporation (NYSE:WAT) unveiled the HPLC CONNECT software, a comprehensive software solution designed to facilitate seamless digita...
February 29, 2024 | News
Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development
This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...
February 23, 2024 | News
Thermo Fisher Scientific Awards Latest Oncomine Clinical Research Grants to Propel Oncology Advances
Thermo Fisher Scientific has unveiled the latest recipients of its Oncomine Clinical Research Grant, a prestigious accolade dedicated to advancing research...
February 21, 2024 | News
GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform
Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...
February 15, 2024 | News
Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...
February 13, 2024 | News
Novo Nordisk's Investment Arm, Novo Holdings, Seals $16.5 Billion Deal to Acquire Catalent in All-Cash Transaction
Catalent, Inc. (NYSE: CTLT), a prominent player in advancing global patient treatment solutions, and Novo Holdings, a holding and investment entity oversee...
February 06, 2024 | News
John Graham, Zuellig Pharma Group CEO, Explores Strategic Partnership with Substipharm Biologics to Transform Healthcare in Asia
In an insightful interview with BioPharma APAC, John Graham, Group CEO of Zuellig Pharma, shares details about the strategic partnership with Substipharm B...
February 05, 2024 | Interaction
World Cancer Day 2024: WHO Regional Director Urges Collective Action for a Cancer-Free Africa
The cancer situation in Africa is alarming, with 1.1 million new cases and 700,000 deaths in 2020. Breast, cervical, prostate, colorectal, and live...
February 04, 2024 | News
Revvity CEO Prahlad Singh Highlights Resilience and Innovation Amidst Industry Challenges in 2023
Revvity, Inc. (NYSE: RVTY) announced robust financial results for Q4 2023 and the full year ending December 31, 2023. Fourth Quarter 2023 Highlights: ...
February 02, 2024 | Company results
LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and availability of a new, FDA-cle...
February 01, 2024 | News
Amcor Expands Thermoforming Capacity for Healthcare Growth in North America
The addition of automated, state-of-the art thermoforming equipment at Amcor's world-class healthcare manufacturing plant in Oshkosh, Wisconsin w...
February 01, 2024 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
